Manufactured in accredited laboratories using advanced peptide synthesis methods, each AOD-9604 vial is independently batch-tested to verify identity, purity, and consistency
A COA is a batch-specific lab report that documents the identity, purity, and quality control results for the production lot you receive
Maintain aseptic technique during all handling and reconstitution steps
AOD 9604 + Semaglutide (advanced) For aggressive fat loss, combining appetite suppression with enhanced fat oxidation can be extremely effective
Cycle Length and Long-Term Use: Initial assessment cycles typically run 12-16 weeks, which aligns with the duration of clinical trials and allows adequate time to evaluate metabolic response and body composition changes
Drug interactions: No known significant interactions